Companies
The companies behind the gauges
Every company in the two gauges and the insurer group, with today’s price and the past 30 days.
Pharma giants
15 companies · pharma gaugeThe largest drug makers, worth $50 billion or more each. Steady cash flow and dividends, with patent expiries as the main risk.
Large biotech
10 companies · biotech gaugeBiotech companies with approved drugs and revenue. Big enough for large funds, but still driven by their pipelines.
Smaller biotech
13 companies · biotech gaugeClinical-stage companies, many without products on the market yet. They feed the breadth and distance-from-high parts of the biotech gauge.
Health insurers
6 companies · compared with XLVShown on their own because they move on medical costs, Medicare rates and regulation rather than drug news.
Reference funds
4 fundsUsed for comparisons, not counted in the gauges themselves.
Companies no longer listed
The baskets only hold shares that still trade. Amicus Therapeutics (FOLD) left the smaller biotech group when BioMarin completed its purchase in April 2026.